Similarly, single-cell studies in JAK2 V617F positive ET patients have demonstrated an expanded population of megakaryocyte primed HSCs with increased sensitivity to interferon alpha signalling [125]. The gene discussed is JAK2; the disease is essential thrombocythemia.